Islet Scis., Inc. v. Brighthaven Ventures, LLC

2017 NCBC 17
North Carolina Business Court·Decided March 6, 2017·No. 15-CVS-16388·Published

Opinion

Islet Scis., Inc. v. Brighthaven Ventures, LLC, 2017 NCBC 17.

STATE OF NORTH CAROLINA IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION COUNTY OF WAKE 15 CVS 16388

ISLET SCIENCES, INC. ) Plaintiff, ) ) v. ) OPINION AND ORDER ON ) THIRD-PARTY DEFENDANTS BRIGHTHAVEN VENTURES, LLC, ) JOHN STEEL, EDWARD JAMES GREEN, WILLIAM WILKISON, ) GIBSTEIN, & COVA CAPITAL OFSINK LLC, and DARREN OFSINK, ) PARTNERS LLC’S MOTION Defendants, ) TO DISMISS ) and ) ) BRIGHTHAVEN VENTURES LLC, ) Third-Party Plaintiff, ) ) v. ) ) JOHN F. STEEL, IV, EDWARD T. ) GIBSTEIN, and COVA CAPITAL ) PARTNERS, LLC, ) Third-Party Defendants. )

THIS MATTER comes before the Court on Third-Party Defendants John F.

Steel, Edward T. Gibstein, and COVA Capital Partners, LLC’s (collectively, “Third-

Party Defendants”) Motion to Dismiss Defendant Brighthaven Ventures LLC’s Third-

Party Complaint (“Motion to Dismiss”).

THE COURT, after considering the Motion to Dismiss, the briefs in support of

and in opposition to the Motion to Dismiss, the arguments of counsel at the hearing,

and other appropriate matters of record, concludes that the Motion to Dismiss should

be GRANTED, in part, and DENIED, in part, for the reasons set forth below.

McGuireWoods LLP by Michael F. Easley, Jr, Esq., Irving M. Brenner, Esq., Michael L. Simes, Esq., for Plaintiff Islet Sciences, Inc. and for Third-Party Defendants John F. Steel, IV, Edward T. Gibstein and COVA Capital Partners, LLC.

Parry Tyndall White by K. Allan Parry, Esq., for Defendants James Green and William Wilkison.

Jerry Meek, PLLC by Gerald F. Meek, Esq. for Defendant Brighthaven Ventures, LLC.

Young Moore and Henderson, P.A. by Walter E. Brock, Jr., Esq. for Defendants Ofsink LLC and Darren Ofsink.

McGuire, Judge.

I. FACTUAL AND PROCEDURAL BACKGROUND.

1. The factual and procedural background of this matter has been recited

by the Court in its Opinion and Order on Green and Wilkison’s Motions and its

Opinion and Order on Defendant Brighthaven, LLC’s Motion to Dismiss issued on

January 12, 2017. Here, the Court recites only those background and procedural facts

necessary to the resolution of the Motion to Dismiss.1

2. Plaintiff Islet Sciences, Inc. (“Islet” or “Plaintiff”) is a public corporation

organized and existing under the laws of the State of Nevada with its headquarters

in Raleigh, North Carolina. Islet is in the business of developing and commercializing

new medicines and technologies to treat patients suffering from metabolic disease.

John F. Steel (“Steel”) was Islet’s largest shareholder and at all times relevant to this

matter was on Islet’s Board of Directors.

1 The background facts are drawn from the allegations in BHV’s Third-Party Complaint (hereinafter “Third-Party Compl.”) and BHV’s Counterclaims (hereinafter “Countercl.”), which are expressly incorporated into the Third-Party Complaint (Third-Party Compl. ¶¶ 5, 10, 15, and 20.) 3. Defendant Brighthaven Ventures, LLC (“BHV”) is a privately-owned

pharmaceutical research and development company headquartered in Raleigh, North

Carolina. BHV develops pharmaceutical products to treat obesity-related health

complications. Defendants James Green (“Green”) and William Wilkison (“Wilkison”)

own BHV.

4. At all times relevant to this lawsuit, BHV was developing the SGLT2

inhibitor remoglifozin etzbonate (“Remo”) to treat type 2 diabetes and nonalcoholic

steatohepatitis under a licensing agreement with Kissei Pharmaceuticals (“Kissei”),

the original creator and developer of Remo.

5. COVA Capital Partners, LLC (“COVA”), a New York limited liability

company, is an investment banker. Edward T. Gibstein (“Gibstein”) is the CEO and

owner of COVA.

6. On August 6, 2013, Islet signed an engagement agreement with COVA.

Under the agreement, COVA was to provide investment banking services to Islet and

raise funds for Islet in exchange for a commission on all amounts raised. On

September 10, 2013, BHV entered into a “Mutual Nondisclosure Agreement” with

COVA pursuant to which the parties agreed not to use or disclose “Confidential

Information” belonging to either party or to any third party for two years. (Mem.

Supp. Mot. Dismiss Third-Party Compl., Ex. C – Mutual Nondisclosure Agreement.)

7. By September 2013, discussions began between Islet, COVA, Gibstein,

and BHV concerning BHV granting a sublicense to Islet for the development of Remo.

BHV contends that “Gibstein, COVA, and Islet knew that BHV was not interested in entering into a relationship with Islet for the development of Remo, except pursuant

to a license agreement,” and that Green and Wilkison were not interested in becoming

directors or officers of Islet “unless BHV and Islet entered into a license agreement

for Remo.” (Countercl. ¶ 4.)

8. On October 29, 2013, Gibstein, acting on behalf of COVA and Islet,

represented to BHV, through Green and Wilkison, that BHV and Islet had reached

an agreement for the license of Remo and that Islet’s board of directors supported the

agreement. On October 30, 2013, in reliance upon Gibstein’s representation, Green

and Wilkison accepted their appointments as the CEO and COO, respectively, of Islet

and members of Islet’s board of directors.

9. BHV also alleges that in reliance on the representation that Islet and

BHV had reached agreement on a license for Remo, BHV “changed course with

respect to the development of Remo,” “deferred pursuit of funding opportunities for

the further development of Remo while the agreement with Islet was being finalized,”

and missed a “window of opportunity . . . to obtain funding for further development

of Remo.” (Countercl. ¶ 8.)

10. Despite the representation that the parties had an agreement to license

Remo, Gibstein, COVA, and Islet “began to repudiate the license of Remo” and

“instead promote a merger between Islet and BHV.” (Countercl. ¶ 9.) BHV alleges

that once Gibstein, COVA, and Islet repudiated the proposed license agreement, it

“considered the proposed merger to be its only realistic alternative.” (Countercl. ¶ 10.) 11. On March 12, 2014, BHV entered into a Binding Letter of Intent with

Islet pursuant to which Islet would acquire BHV. On September 30, 2014, BHV and

Islet entered into an Agreement and Plan of Merger (“Merger Agreement”). Both the

Letter of Intent and the Merger Agreement provided that Islet would be responsible

for all costs and expenses of the merger transaction. (Countercl. ¶¶ 11–12.)

12. Steel initially supported the Merger Agreement, believing the proposed

merger would increase the value of his Islet stock. Contrary to his expectations,

however, following the public announcement of the Merger Agreement, Islet’s share

price did not increase significantly. (Countercl. ¶¶ 13–14.) Concerned that his

ownership in Islet would be diluted, Steel “conspir[ed] with Gibstein, Richard

Schoninger, and others, [to launch] a campaign to replace the agreed upon Merger

Agreement with a new merger agreement that minimized the risk that his shares

would be diluted.” (Countercl. ¶ 14.)

13. Ultimately, a majority of disinterested Islet directors agreed to

terminate the Merger Agreement and, instead, enter into an exclusive license

agreement for the development of Remo. (Countercl. ¶ 15.) On March 3, 2015, Islet

and BHV entered into an agreement terminating the Merger Agreement

(“Termination Agreement”). (Countercl.

Free access — add to your briefcase to read the full text and ask questions with AI

Islet Scis., Inc. v. Brighthaven Ventures, LLC, 2017 NCBC 17 (N.C. Super. Ct. 2017).

2017 NCBC 17 (Islet Scis., Inc. v. Brighthaven Ventures, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Central Freight Lines Inc. v. APA Transport Corp.
322 F.3d 376 (Fifth Circuit, 2003)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Ce Distribution, LLC v. New Sensor Corporation
380 F.3d 1107 (Ninth Circuit, 2004)
Cambridge Homes of North Carolina Ltd. Partnership v. Hyundai Construction, Inc.
670 S.E.2d 290 (Court of Appeals of North Carolina, 2008)
Jackson v. Bumgardner
347 S.E.2d 743 (Supreme Court of North Carolina, 1986)
Peoples Security Life Insurance v. Hooks
367 S.E.2d 647 (Supreme Court of North Carolina, 1988)
Dillon v. Numismatic Funding Corp.
231 S.E.2d 629 (Supreme Court of North Carolina, 1977)
Harris v. NCNB National Bank of North Carolina
355 S.E.2d 838 (Court of Appeals of North Carolina, 1987)
Good Hope Hospital, Inc. v. North Carolina Department of Health & Human Services
620 S.E.2d 873 (Court of Appeals of North Carolina, 2005)
Reichhold Chemicals, Inc. v. Goel
555 S.E.2d 281 (Court of Appeals of North Carolina, 2001)
Odom v. Little Rock & I-85 Corp.
261 S.E.2d 99 (Supreme Court of North Carolina, 1980)
Sutton v. Duke
176 S.E.2d 161 (Supreme Court of North Carolina, 1970)
Braun v. Glade Valley School, Inc.
334 S.E.2d 404 (Court of Appeals of North Carolina, 1985)
Pinewood Homes, Inc. v. Harris
646 S.E.2d 826 (Court of Appeals of North Carolina, 2007)
Laster v. Francis
681 S.E.2d 858 (Court of Appeals of North Carolina, 2009)
United Laboratories, Inc. v. Kuykendall
370 S.E.2d 375 (Supreme Court of North Carolina, 1988)
Boudreau v. Baughman
368 S.E.2d 849 (Supreme Court of North Carolina, 1988)